Finance

Lists
Why is KRRO up ३.०५%?
Dive Deeper
KRRO:NASDAQ
Korro Bio Inc
US$ १५.१८
+३.०५%
(+०.४५) 1D
नोभेम्बर ६, १३:५२:१८ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRRO...
Open
US$ १४.७४
High
US$ १५.७४
Low
US$ १४.७४
Mkt. cap
२२.३५ करोड
Avg. vol.
२.०६ लाख
Volume
३३.४७ हजार
52-wk high
US$ ३६.७९
52-wk low
US$ ५.२०
EPS
-US$ १०.००
Beta
३.२३
Shares outstanding
१.४७ करोड
No. of employees
५७
Open
US$ १४.७४
High
US$ १५.७४
Low
US$ १४.७४
Mkt. cap
२२.३५ करोड
Avg. vol.
२.०६ लाख
Volume
३३.४७ हजार
52-wk high
US$ ३६.७९
52-wk low
US$ ५.२०
EPS
-US$ १०.००
Beta
३.२३
Shares outstanding
१.४७ करोड
No. of employees
५७
News stories
From web sources and news partners
About Korro Bio Inc
CEO-
Employees५७
Founded२०१४
Headquarters-
SectorHealth Care
Industry-
Websitekorrobio.com
Analyst ratings
Based on 7 analysts giving stock ratings to KRRO in the past 3 months
Strong buy
Buy
6
Hold
1
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for KRRO in the last 3 months.
Highest
Current US$ १५.१८
US$ ३०.०० (+९७.६३%)
Average
US$ १९.५७ (+२८.९२%)
Lowest
US$ १०.०० (-३४.१२%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luca Issi
RBC Capital
Hold
Maintained
US$ १०.००
-३४.१%
11/05/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
US$ २१.००
+३८.३%
11/05/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
US$ १५.००
-१.२%
11/06/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
US$ २२.००
+४४.९%
10/28/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
US$ ३०.००
+९७.६%
10/06/2026
Unknown Analyst
LifeSci Capital
Buy
Maintained
US$ २१.००
+३८.३%
10/06/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
US$ २२.००
+४४.९%
10/06/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
US$ २२.००
+४४.९%
08/06/2026
William Maughan
Clear Street
Buy
Maintained
US$ १८.००
+१८.६%
08/07/2026
Myles Minter
William Blair
Buy
Maintained
-
-
08/06/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
US$ १५.००
-१.२%
08/06/2026
Catherine Novack
JonesTrading
Buy
Upgraded
US$ २३.००
+५१.५%
05/08/2026
Ryan Deschner
Raymond James
Buy
Upgraded
US$ २३.००
+५१.५%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१०.९० लाख
१२.९२ लाख
-
-
Cost of goods sold
१.१३ करोड
८५.९९ लाख
१.१५ करोड
१.१६ करोड
Cost of revenue
१.१३ करोड
८५.९९ लाख
१.१५ करोड
१.१६ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
९०.६३ लाख
८५.७६ लाख
८९.०६ लाख
८४.७९ लाख
Operating expense
९०.६३ लाख
८५.७६ लाख
८९.०६ लाख
८४.७९ लाख
Total operating expenses
२.०३ करोड
१.७२ करोड
२.०४ करोड
२.०१ करोड
Operating income
-१.९२ करोड
-१.५९ करोड
-२.०४ करोड
-२.०१ करोड
Other non operating income
११.७६ लाख
९.९० लाख
-
-
EBT including unusual items
-१.८१ करोड
-४.९४ करोड
-१.९५ करोड
-१.८८ करोड
EBT excluding unusual items
-१.८१ करोड
-१.४९ करोड
-१.९५ करोड
-१.८८ करोड
Income tax expense
-
६.३६ लाख
९५.०० हजार
१.०८ लाख
Effective tax rate
-
-१.२९%
-०.४९%
-०.५७%
Other operating expenses
-
-
-
-
Net income
-१.८१ करोड
-५.०० करोड
-१.९६ करोड
-१.८९ करोड
Net profit margin
-१,६५६.९७%
-३,८७३.२२%
-
-
Earnings per share
-१.९२
-१.६५
-१.६९
-१.०७
Interest and investment income
-
-
९.०६ लाख
१३.०२ लाख
Interest expense
-
-
-
-
Net interest expenses
-
-
९.०६ लाख
१३.०२ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-१.८१ करोड
-१.५२ करोड
-२.०१ करोड
-१.९७ करोड
Gain or loss from assets sale
-
-१८.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू